| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A synthesized peptide derived from human LAP3 was used as the immunogen for the LAP3 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
LAP3 Antibody / Leucine aminopeptidase 3 is an antibody targeting LAP3. Host: Rabbit. Monoclonal. Clone: 31L65. Format: Liquid. Applications: WB, IHC.
Key elements and design rationale
- Target: LAP3.
- Immunogen: A synthesized peptide derived from human LAP3 was used as the immunogen for the LAP3 antibody..
- Species reactivity: Human.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
LAP3 antibody detects leucine aminopeptidase 3, a cytosolic enzyme that catalyzes the removal of N-terminal amino acids, particularly leucine, from peptides. LAP3 is involved in protein degradation, antigen processing, and amino acid recycling.
Common research applications
- WB: relative abundance and band pattern assessment using appropriate controls.
- IHC: tissue distribution assessment; interpret with matched controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.